Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Biogen, AbbVie yank MS drug Zinbryta off the market in the wake of encephalitis cases
Endpoints
Fri, 03/2/18 - 11:08 am
Tags:
Biogen, AbbVie, MS, multiple sclerosis, Zinbryta, Europe, encephalitis
AbbVie rolls up another big win for elagolix as the prospective blockbuster sweeps endpoints in latest PhIII
Endpoints
Wed, 02/21/18 - 09:36 am
Tags:
AbbVie, Elagolix, endometriosis, uterine fibroids
With $69M Deal, AbbVie Turns to Voyager for an Alzheimer’s Gene Therapy
Xconomy
Tue, 02/20/18 - 10:58 pm
Tags:
AbbVie, Voyager Therapeutics, gene therapy, Alzheimer's disease
AbbVie Presents New Data on Upadacitinib for Crohn's Disease
Yahoo/Zacks.com
Mon, 02/19/18 - 04:18 pm
Tags:
AbbVie, Upadacitinib, Crohn's Disease
AbbVie, Allergan, Roche could join Biogen, UCB in Acorda hunt: analyst
Fierce Pharma
Fri, 02/16/18 - 09:38 pm
Tags:
AbbVie, Allergan, Roche, Biogen, UCB Pharma, Acorda Therapeutics, M&A
Top 10 most productive workforces in biopharma
Fierce Pharma
Mon, 02/12/18 - 11:03 am
Tags:
Pharma, pharma employees, productivity, Gilead Sciences, Celgene, Pfizer, AbbVie, Biogen
These 3 Drugs Are Critical to AbbVie's Success
Motley Fool
Mon, 02/12/18 - 09:10 am
Tags:
AbbVie, Rova-T, Upadacitinib, risankizumab
Watch These Biotechs and the FDA Calendar
TheStreet.com
Sun, 02/11/18 - 01:23 pm
Tags:
FDA, biotech, Dynavax, HEPLISAV-B, Progenics, Azedra, Neurocrine, Elagolix, AbbVie
ABBV to Focus on Advancing Late-Stage Immunology Research in 2018
Market Realist
Thu, 02/8/18 - 11:17 am
Tags:
AbbVie, R&D, immunology, Upadacitinib, risankizumab
Dogged by AbbVie's new share-stealing Mavyret, Gilead's hep C forecast comes in far short
Fierce Pharma
Thu, 02/8/18 - 09:14 am
Tags:
AbbVie, Mavyret, Gilead Sciences, hepatitis C, Harvoni, Sovaldi
AbbVie, Pfizer in another close TV ad spending race to kick off 2018
Fierce Pharma
Wed, 02/7/18 - 10:02 am
Tags:
AbbVie, Pfizer, drug ads, television ads
Biopharma in charts: Key takeaways from Q4 earnings
Biopharma Dive
Mon, 02/5/18 - 12:35 pm
Tags:
earnings, Merck, JNJ, AbbVie, Roche, Celgene, Eli Lilly
3 Big Biotech Stocks With Major Catalysts on the Way
Motley Fool
Tue, 01/30/18 - 09:50 am
Tags:
biotech, AbbVie, Neurocrine Biosciences, Elagolix, Celgene, ozanimod, Gilead Sciences, bictegravir
Why big pharma companies always create new spinoffs
GoinPharma
Sun, 01/28/18 - 10:06 am
Tags:
spinoffs, Sanofi, Celgene, Biogen, AbbVie, Abbott Labs, Baxalta, Shire
AbbVie wins U.S. trial in lawsuit over AndroGel's risks
Yahoo/Reuters
Sat, 01/27/18 - 09:38 am
Tags:
AbbVie, Androgel, pulmonary embolism
Why AbbVie (ABBV) Might Surprise This Earnings Season
Yahoo/Zacks.com
Thu, 01/25/18 - 09:33 am
Tags:
AbbVie, earnings
5 Highest-Growth Drugs of 2018 -- and Who Will Get Rich from Them
Motley Fool
Sun, 01/21/18 - 10:53 am
Tags:
Merck, Keytruda, AbbVie, Humira, Mavyret, Bristol-Myers Squibb, Eliquis, Pfizer, Ibrance
Novartis aims for US approval of Humira biosimilar
Biopharma Dive
Wed, 01/17/18 - 09:55 pm
Tags:
Novartis, Humira, biosimilars, AbbVie, Sandoz
Why AbbVie's Upadacitinib Keeps Posting Strong Data for Rheumatoid Arthritis
Market Realist
Mon, 01/8/18 - 09:42 am
Tags:
AbbVie, Upadacitinib, rheumatoid arthritis
2018 Healthcare And Biotech Outlook
Seeking Alpha
Sun, 01/7/18 - 12:41 pm
Tags:
AbbVie, Abbott Labs, Amgen, Allergan, AstraZeneca, Gilead Sciences, Bristol-Myers Squibb

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.